Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders. - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Patents Year : 2016

Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders.

Domains

Life Sciences [q-bio]

Migration ProdInra  : Connect in order to contact the contributor

https://hal.inrae.fr/hal-02795779

Submitted on : Friday, June 5, 2020-1:00:32 PM

Last modification on : Sunday, May 26, 2024-3:16:07 AM

No file

Dates and versions

hal-02795779 , version 1 (05-06-2020)

Identifiers

  • HAL Id : hal-02795779 , version 1
  • PRODINRA : 449866

Cite

Bruno Lamas, Harry Sokol, Philippe Langella, Jane Mea Natividad, Mathias Lavie-Richard, et al.. Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders.. France, Patent n° : EP16306300.1. 2016. ⟨hal-02795779⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

AGROPARISTECH INRA UNIV-PARIS-SACLAY INRAE GS-BIOSPHERA GS-HEALTH-DRUG-SCIENCES TOXALIM INRAEOCCITANIETOULOUSE TOXALIM-ENTERISK MICALIS TOULOUSE-INP UNIV-UT3 UT3-TOULOUSEINP EIPURPAN PROBIHOTE-MICALIS
15 View
0 Download

Share

More